13.07.2015 Views

2010 BC Guide in Determining Fitness to Drive

2010 BC Guide in Determining Fitness to Drive

2010 BC Guide in Determining Fitness to Drive

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

GUIDELINES29.6 Private and commercial drivers who use psychotropic drugsApplicationAssessment guidel<strong>in</strong>es<strong>Fitness</strong> guidel<strong>in</strong>esOSMVdeterm<strong>in</strong>ationguidel<strong>in</strong>esConditionsRestrictionsThese guidel<strong>in</strong>es apply <strong>to</strong> driver fitness determ<strong>in</strong>ations for privateand commercial drivers who are us<strong>in</strong>g psychotropic drugs.If the treat<strong>in</strong>g physician, or cognitive screen<strong>in</strong>g, <strong>in</strong>dicates possiblepersistent impairment of the cognitive functions necessary fordriv<strong>in</strong>g, OSMV will request a <strong>Drive</strong>ABLE assessment, unless therehas been no significant change <strong>in</strong> the <strong>in</strong>dividual’s condition orcognitive ability s<strong>in</strong>ce a previous functional assessment.Otherwise, OSMV will not generally request further <strong>in</strong>formation.OSMV will consider the follow<strong>in</strong>g po<strong>in</strong>ts when mak<strong>in</strong>g a driverfitness determ<strong>in</strong>ation <strong>in</strong> relation <strong>to</strong> the use of drugs: OSMV is primarily concerned with the persistent cognitiveimpairment associated with the effects or side effects ofmedication used for ongo<strong>in</strong>g treatment of medical conditions. Temporary impairments from short-term treatment or changes <strong>in</strong>dosage or type of medication are considered transientimpairments for licens<strong>in</strong>g purposes. In these circumstances, theprescrib<strong>in</strong>g physician should advise patients not <strong>to</strong> drive until theeffect of a drug is known. Where there is evidence of somepersistent cognitive impairment caused by a stable dose,<strong>in</strong>dividuals should be assessed for fitness <strong>to</strong> drive. Where an <strong>in</strong>dividual is tak<strong>in</strong>g multiple drugs (poly-pharmacy),OSMV will consider the potential compound<strong>in</strong>g effects. Whererelevant, OSMV will also consider the potential compound<strong>in</strong>geffect of the use of alcohol or illicit drugs.OSMV may f<strong>in</strong>d <strong>in</strong>dividuals fit <strong>to</strong> drive if: the treat<strong>in</strong>g physician or cognitive screen<strong>in</strong>g does not <strong>in</strong>dicatepossible persistent impairment of the cognitive functionsnecessary for driv<strong>in</strong>g, or where the treat<strong>in</strong>g physician or cognitive screen<strong>in</strong>g <strong>in</strong>dicatespossible impairment of the cognitive functions necessary fordriv<strong>in</strong>g, a functional assessment <strong>in</strong>dicates that they have thefunctional ability required for their class of licence heldNo conditions are required.No restrictions are required.364

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!